These compounds inhibit cancer cell proliferation by downregulating cyclin D1 and upregulating caveolin-1, while simultaneously activating both intrinsic and extrinsic apoptotic pathways to induce cell death, including common epithelial carcinomas, myeloma, leukemia, and sarcoma [464,466,467]. The gene discussed is CCND1; the disease is cancer.